Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

British Journal of Haematology

Volumn 91, Issue 1, 1995, Pages 245-252

  Maciejewski, Jaroslaw P ^a   Selleri, Carmine ^a   Sato, Tadatsugu ^a   Anderson, Stacie ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

aplastic anaemia; bone marrow; CD34+ cells; Fas antigen; progenitors

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ANEMIA, APLASTIC; ANTIGENS, CD34; ANTIGENS, CD95; BONE MARROW; CELLS, CULTURED; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMAN; MYELODYSPLASTIC SYNDROMES; RECEPTORS, CELL SURFACE;

EID: 0029048258     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb05277.x     Document Type: Article

References (54)

1. Antithymocyte globulin, cyclosporin, and granulocyte colony‐stimulating factor in patients with aquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party
2. Multiple sclerosis: pathogenesis and treatment
3. Proposals for the classification of the myelodysplastic syndromes
4. Epstein Barr virus in the bone marrow of patients with aplastic anemia
5. Severe aplastic anemia: a prospective study of the effect of early transplantation on acute mortality
6. Type‐I diabetes: a chronic autoimmune disease of human, mouse and rat
7. Protection from Fas‐mediated apoptosis by a soluble form of the Fas molecule
8. Antigenic analysis of hematopoiesis. VI. Characterization of my‐10‐positive progenitor cells in normal human bone marrow
9. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by monoclonal antibody raised against KG‐la cells
10. APO‐1‐induced apoptosis of leukemia cells from patients with adult T‐cell leukemia
11. High expression of APO‐1 (CD95) on T lymphocytes from human immunodeficiency virus‐1‐infected children. (Letter)
12. Fas and its ligand in a general mechanism of T‐cell‐mediated cytotoxicity
13. The presence of apoptosis in refractory anemia of myelodysplasia
14. Hepatitis/ aplasia syndrome: non A, non B, non C
15. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
16. Suppression of erythroid‐colony formation by lymphocytes from patients with aplastic anemia
17. The polypeptide sequence encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
18. Fas and perforin pathways as major mechanisms of T‐cell mediated cytotoxicity
19. Increased expression of TNF‐beta in patients with aplastic anemia. (Abstract)
20. Expression of functional Fas antigen on adult T‐cell leukemia
21. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure
22. Expression of a stem cell inhibitor (SCI/LD78) gene in patients with bone marrow failure
23. + human marrow cells is induced by interferon‐γ and tumor necrosis factor‐α and potentiates cytokine‐mediated hematopoietic suppression in vitro
24. Autoimmune myelopathies
25. Autoimmune myelodysplasias
26. Interferon gamma gene expression in unstimulated bone marrow mononuclear cells predicts a response to cyclosporine therapy in aplastic anemia
27. Peripheral blood cells from patients with aplastic anaemia in partial remission suppress growth of their own bone marrow precursors in culture
28. Gamma‐interferon gene expression in the bone marrow of patients with acquired aplastic anemia
29. Purification and molecular cloning of the Apo‐1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen
30. Selective targeting of the immune response in autoimmune demyelination
31. Fas/APO‐1 expression and function on malignant cells of hematologic and non‐hematologic origin
32. Is hepatitis C virus involved in hepatitis‐associated aplastic anemia? Annals
33. Viruses and bone marrow failure
34. Improved response rate of severe aplastic anemia to intensive immunosuppression with antithymocyte globulin and cyclosporin
35. Paroxysmal nocturnal haemoglobi‐nuria
36. 2+‐independent T‐cell‐mediated cytotoxicity
37. Haemopoietic progenitor cells are reduced in aplastic anaemia
38. Coculture studies of sixteen untransfused patients with aplastic anemia
39. + human hematopoietic progenitor cells
40. Cells with Fc‐γ from normal donors suppress granulocytic macrophage colony formation
41. Antithymocyte globulin for hypoplastic myelodysplastic syndrome
42. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
43. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells
44. In vitro tests for distinguishing possible immune‐mediated aplastic anemia from transfusion‐induced sensitization
45. Measurement of serum cytokine levels in patients with myelodysplastic syndromes
46. Analysis at the clonal level of T cell phenotype and functions in severe aplastic anemia patients
47. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
48. The problem of clonality in aplastic anemia. Dr Dameshek's riddle, restated
49. The treatment of severe aplastic anemia
50. A multicenter trial of antithymocyte globulin in bone marrow failure
51. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro
52. Circulating activated suppressor T lymphocytes in aplastic anemia